Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
7.
An Bras Dermatol ; 93(1): 135-137, 2018.
Article in English | MEDLINE | ID: mdl-29641717

ABSTRACT

Trichothiodystrophy refers to a heterogeneous group of rare genetic diseases that affects neuroectodermal-derived tissues with multisystem involvement. The hallmark of these syndromes is the deficiency of sulfur in hair matrix proteins, leading to short and brittle hair. Few cases of this rare disorder have been published. The authors report a case of trichothiodystrophy in a male infant with ichthyosis, photosensitivity, spastic paraparesis, short stature, and neurologic and psychomotor retardation. Diagnosis was based on clinical and microscopic features of hair samples.


Subject(s)
Abnormalities, Multiple/diagnosis , Ichthyosis/diagnosis , Intellectual Disability/diagnosis , Trichothiodystrophy Syndromes/diagnosis , Child, Preschool , Humans , Ichthyosis/complications , Intellectual Disability/complications , Male , Photosensitivity Disorders/complications , Trichothiodystrophy Syndromes/complications
8.
An. bras. dermatol ; 93(1): 135-137, Jan.-Feb. 2018. graf
Article in English | LILACS | ID: biblio-887143

ABSTRACT

Abstract: Trichothiodystrophy refers to a heterogeneous group of rare genetic diseases that affects neuroectodermal-derived tissues with multisystem involvement. The hallmark of these syndromes is the deficiency of sulfur in hair matrix proteins, leading to short and brittle hair. Few cases of this rare disorder have been published. The authors report a case of trichothiodystrophy in a male infant with ichthyosis, photosensitivity, spastic paraparesis, short stature, and neurologic and psychomotor retardation. Diagnosis was based on clinical and microscopic features of hair samples.


Subject(s)
Humans , Male , Child, Preschool , Abnormalities, Multiple/diagnosis , Trichothiodystrophy Syndromes/diagnosis , Ichthyosis/diagnosis , Intellectual Disability/diagnosis , Photosensitivity Disorders/complications , Trichothiodystrophy Syndromes/complications , Ichthyosis/complications , Intellectual Disability/complications
10.
Arq Neuropsiquiatr ; 73(6): 531-43, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26083891

ABSTRACT

Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of different specialists for proper treatment and genetic counseling, especially in NF2 and SCH. The present text suggests guidelines for the clinical management of NF, with emphasis on NF1.


Subject(s)
Neurilemmoma/therapy , Neurofibromatoses/therapy , Neurofibromatosis 1/therapy , Neurofibromatosis 2/therapy , Skin Neoplasms/therapy , Disease Management , Humans , Neurilemmoma/complications , Neurilemmoma/pathology , Neurofibromatoses/complications , Neurofibromatoses/pathology , Neurofibromatosis 1/complications , Neurofibromatosis 1/pathology , Neurofibromatosis 2/complications , Neurofibromatosis 2/pathology , Optic Nerve Glioma/pathology , Optic Nerve Glioma/therapy , Risk Factors , Skin Neoplasms/complications , Skin Neoplasms/pathology
11.
Arq. neuropsiquiatr ; 73(6): 531-543, 06/2015. tab, graf
Article in English | LILACS | ID: lil-748178

ABSTRACT

Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of different specialists for proper treatment and genetic counseling, especially in NF2 and SCH. The present text suggests guidelines for the clinical management of NF, with emphasis on NF1.


A primeira parte desta diretriz abordou o diagnóstico diferencial das neurofibromatoses (NF): neurofibromatose do tipo 1 (NF1), neurofibromatose do tipo 2 (NF2) e schwannomatose (SCH). As NF compartilham algumas características, como a origem neural dos tumores e sinais cutâneos, e afetam cerca de 80 mil brasileiros. O aumento do conhecimento científico sobre as NF tem permitido melhor manejo clínico e redução da morbidade das complicações, resultando em melhor qualidade de vida para os pacientes com NF. A maioria dos médicos é capaz de realizar o diagnóstico das NF, mas a variedade de manifestações clínicas e a dificuldade de se prever o surgimento e a gravidade de complicações, torna o manejo da NF um desafio para o clínico e envolve diferentes especialistas para o tratamento adequado e aconselhamento genético, especialmente a NF2 e a SCH. O presente texto sugere algumas orientações para o acompanhamento dos portadores de NF, com ênfase na NF1.


Subject(s)
Humans , Neurilemmoma/therapy , Neurofibromatoses/therapy , Neurofibromatosis 1/therapy , /therapy , Skin Neoplasms/therapy , Disease Management , Neurilemmoma/complications , Neurilemmoma/pathology , Neurofibromatoses/complications , Neurofibromatoses/pathology , Neurofibromatosis 1/complications , Neurofibromatosis 1/pathology , /complications , /pathology , Optic Nerve Glioma/pathology , Optic Nerve Glioma/therapy , Risk Factors , Skin Neoplasms/complications , Skin Neoplasms/pathology
12.
An Bras Dermatol ; 89(2): 293-9, 2014.
Article in English | MEDLINE | ID: mdl-24770507

ABSTRACT

Impetigo is a common cutaneous infection that is especially prevalent in children. Historically, impetigo is caused by either group A ß-hemolytic streptococci or Staphylococcus aureus. Currently, the most frequently isolated pathogen is S. aureus. This article discusses the microbiologic and virulence factors of group A ß-hemolytic streptococci and Staphylococcus aureus, clinical characteristics, complications, as well as the approach to diagnosis and management of impetigo. Topical agents for impetigo therapy are reviewed.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Impetigo/drug therapy , Impetigo/pathology , Administration, Topical , Drug Resistance, Bacterial , Humans , Impetigo/microbiology , Staphylococcus/pathogenicity , Streptococcus/pathogenicity
13.
An. bras. dermatol ; 89(2): 293-299, Mar-Apr/2014. graf
Article in English | LILACS | ID: lil-706993

ABSTRACT

Impetigo is a common cutaneous infection that is especially prevalent in children. Historically, impetigo is caused by either group A β-hemolytic streptococci or Staphylococcus aureus. Currently, the most frequently isolated pathogen is S. aureus. This article discusses the microbiologic and virulence factors of group A β-hemolytic streptococci and Staphylococcus aureus, clinical characteristics, complications, as well as the approach to diagnosis and management of impetigo. Topical agents for impetigo therapy are reviewed.


Subject(s)
Humans , Impetigo/pathology , Impetigo/drug therapy , Anti-Bacterial Agents/therapeutic use , Staphylococcus/pathogenicity , Streptococcus/pathogenicity , Administration, Topical , Drug Resistance, Bacterial , Impetigo/microbiology
16.
An Bras Dermatol ; 86(4): 799-802, 2011.
Article in English, Portuguese | MEDLINE | ID: mdl-21987155

ABSTRACT

Cutaneous lymphomas comprise a heterogeneous group of lymphoproliferative disorders with skin involvement and are classified as a subgroup of non-Hodgkin lymphomas. From 1981 to 2007, 100 children with non-Hodgkin lymphomas were admitted to the Hematology Unit of the Federal University of Minas Gerais Teaching Hospital. In nine of these children, the skin was involved at the onset of the disease. Three patients were classified as having primary cutaneous lymphoma, while in six the disease was systemic with cutaneous involvement. In seven patients, the immunophenotype was T-cell, in one it was B-cell, and in the remaining case the immunophenotype was indefinable. No deaths occurred in any of the children with primary cutaneous lymphoma.


Subject(s)
Lymphoma, T-Cell, Cutaneous/pathology , Skin Neoplasms/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Prognosis , Retrospective Studies
17.
An. bras. dermatol ; 86(4): 799-802, jul.-ago. 2011. ilus, tab
Article in Portuguese | LILACS | ID: lil-600631

ABSTRACT

Os linfomas cutâneos compreendem um grupo heterogêneo de desordens linfoproliferativas que envolvem a pele e são classificados como um subgrupo dos linfomas não Hodgkin. No período de 1981 a 2007, 100 casos de linfomas em crianças foram admitidos no Serviço de Hematologia, do Hospital das Clínicas da Universidade Federal de Minas Gerais, sendo que nove apresentaram manifestação cutânea inicial. Três pacientes foram classificados como linfoma cutâneo primário e seis como sistêmicos. Sete pacientes apresentaram linfoma de células T, um, linfoma linfoblástico B e um, imunofenótipo indefinido. Nenhum óbito ocorreu nos pacientes com linfoma cutâneo primário.


Cutaneous lymphomas comprise a heterogeneous group of lymphoproliferative disorders with skin involvement and are classified as a subgroup of non-Hodgkin lymphomas. From 1981 to 2007, 100 children with non-Hodgkin lymphomas were admitted to the Hematology Unit of the Federal University of Minas Gerais Teaching Hospital. In nine of these children, the skin was involved at the onset of the disease. Three patients were classified as having primary cutaneous lymphoma, while in six the disease was systemic with cutaneous involvement. In seven patients, the immunophenotype was T-cell, in one it was B-cell, and in the remaining case the immunophenotype was indefinable. No deaths occurred in any of the children with primary cutaneous lymphoma.


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Lymphoma, T-Cell, Cutaneous/pathology , Skin Neoplasms/pathology , Follow-Up Studies , Prognosis , Retrospective Studies
18.
An Bras Dermatol ; 86(3): 605-7, 2011.
Article in English, Portuguese | MEDLINE | ID: mdl-21738991

ABSTRACT

Keratosis linearis with ichthyosis congenita and sclerosing keratoderma (KLICK) syndrome is a rare autosomal recessive skin disorder characterized by the association of diffuse, transgressive palmoplantar keratoderma with sclerodactyly, linear hyperkeratotic plaques generally located in flexures, and congenital ichthyosis. The patient is physically and mentally healthy and has no history of any problems related to teeth, nails, hair or mucous membranes. Treatment is based on the use of topical keratolytics and oral retinoids.


Subject(s)
Ichthyosis/pathology , Keratoderma, Palmoplantar/pathology , Humans , Male , Syndrome , Young Adult
19.
An. bras. dermatol ; 86(3): 605-607, maio-jun. 2011. ilus
Article in Portuguese | LILACS | ID: lil-592166

ABSTRACT

A síndrome KLICK é uma genodermatose rara, autossômica recessiva, caracterizada pela associação de queratodermia palmo-plantar difusa e transgressiva, com esclerodactilia, placas hiperqueratóticas lineares localizadas preferencialmente em flexuras e ictiose congênita. Não há alterações em fâneros ou mucosas, assim como sintomas sistêmicos associados. O tratamento consiste no uso de queratolíticos tópicos e retinóides orais.


Keratosis linearis with ichthyosis congenita and sclerosing keratoderma (KLICK) syndrome is a rare autosomal recessive skin disorder characterized by the association of diffuse, transgressive palmoplantar keratoderma with sclerodactyly, linear hyperkeratotic plaques generally located in flexures, and congenital ichthyosis. The patient is physically and mentally healthy and has no history of any problems related to teeth, nails, hair or mucous membranes. Treatment is based on the use of topical keratolytics and oral retinoids.


Subject(s)
Humans , Male , Young Adult , Ichthyosis/pathology , Keratoderma, Palmoplantar/pathology , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...